Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.

Otsuka M, Kato N, Lan K, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M.

J Biol Chem. 2000 Nov 3;275(44):34122-30.

2.

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.

Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD.

Oncogene. 2002 Jul 18;21(31):4801-11.

3.
4.

Activation of p53 tumor suppressor by hepatitis C virus core protein.

Lu W, Lo SY, Chen M, Wu Kj, Fung YK, Ou JH.

Virology. 1999 Nov 10;264(1):134-41.

5.

HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines.

Siavoshian S, Abraham JD, Kieny MP, Schuster C.

Arch Virol. 2004 Feb;149(2):323-36. Epub 2003 Sep 22.

PMID:
14745598
6.
7.

Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.

Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D.

J Biol Chem. 2001 Aug 3;276(31):29116-25. Epub 2001 May 30.

8.

ING1 represses transcription by direct DNA binding and through effects on p53.

Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K.

Cancer Res. 2003 Sep 15;63(18):5785-92.

9.

[Regulation mechanism of HCV NS5A on p53 protein transactivity].

Gong GZ, Jiang YF, Zhu YH, Su XS.

Zhonghua Gan Zang Bing Za Zhi. 2003 Mar;11(3):162-5. Chinese.

PMID:
12681065
10.
11.

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

McPherson LA, Loktev AV, Weigel RJ.

J Biol Chem. 2002 Nov 22;277(47):45028-33. Epub 2002 Sep 10.

12.

Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.

Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y, Omata M.

J Med Virol. 2004 Jan;72(1):52-9.

PMID:
14635011
13.
14.

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M.

Hepatology. 2000 Aug;32(2):405-12.

PMID:
10915750
16.

YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.

Yakovleva T, Kolesnikova L, Vukojević V, Gileva I, Tan-No K, Austen M, Lüscher B, Ekström TJ, Terenius L, Bakalkin G.

Biochem Biophys Res Commun. 2004 May 28;318(2):615-24.

PMID:
15120643
17.

p53-dependent down-regulation of telomerase is mediated by p21waf1.

Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, Kogan I, Braunstein I, Tzukerman M, Ginsberg D, Rotter V.

J Biol Chem. 2004 Dec 3;279(49):50976-85. Epub 2004 Sep 15.

18.
19.

Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.

Liu PY, Chan JY, Lin HC, Wang SL, Liu ST, Ho CL, Chang LC, Huang SM.

Mol Cancer Res. 2008 Jul;6(7):1204-14. doi: 10.1158/1541-7786.MCR-08-0123.

20.

Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice.

Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, Matsuura Y, Koike K, Miyamura T.

Hepatology. 2003 Oct;38(4):820-8.

PMID:
14512869

Supplemental Content

Support Center